01 1AQUESTIVE
02 4INDIVIOR
03 3OTTER PHARMS
04 5SUMITOMO PHARMA AM
01 138603514
01 13Blank
01 13Y
01 132024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212640
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22410
Patent Use Code : U-1464
Delist Requested :
Patent Use Description : TREATMENT OF OPIOID DE...
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210875
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210875
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210875
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210875
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
Patent Expiration Date : 2024-04-03
US Patent Number : 8603514
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210875
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2024-04-03
